Page last updated: 2024-08-23

etoposide and neoamphimedine

etoposide has been researched along with neoamphimedine in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Abbott, JM; Abraham, AD; D'Alessandro, A; Esquer, H; Gomez, JD; Gustafson, DL; Hamill, BD; Hansen, KC; LaBarbera, DV; Li, L; Lunghofer, PJ; Messersmith, WA; Nemkov, T; Pike, LA; Ramirez, DA; Rinaldetti, S; Schaack, J; Tomlinson, N; Zhou, Q	1

Other Studies

1 other study(ies) available for etoposide and neoamphimedine

Article	Year
Drug Design Targeting T-Cell Factor-Driven Epithelial-Mesenchymal Transition as a Therapeutic Strategy for Colorectal Cancer. Journal of medicinal chemistry, 2019, 11-27, Volume: 62, Issue:22 Topics: Adenosine Triphosphate; Animals; Binding, Competitive; Cell Line, Tumor; Colorectal Neoplasms; DNA Topoisomerases, Type II; Drug Design; Drug Screening Assays, Antitumor; Epithelial-Mesenchymal Transition; Humans; Mice; Molecular Targeted Therapy; Poly-ADP-Ribose Binding Proteins; Structure-Activity Relationship; TCF Transcription Factors; Topoisomerase II Inhibitors; Transcription, Genetic	2019

Article

Year

Drug Design Targeting T-Cell Factor-Driven Epithelial-Mesenchymal Transition as a Therapeutic Strategy for Colorectal Cancer.

Journal of medicinal chemistry, 2019, 11-27, Volume: 62, Issue:22

Topics: Adenosine Triphosphate; Animals; Binding, Competitive; Cell Line, Tumor; Colorectal Neoplasms; DNA Topoisomerases, Type II; Drug Design; Drug Screening Assays, Antitumor; Epithelial-Mesenchymal Transition; Humans; Mice; Molecular Targeted Therapy; Poly-ADP-Ribose Binding Proteins; Structure-Activity Relationship; TCF Transcription Factors; Topoisomerase II Inhibitors; Transcription, Genetic

2019